Webinar: NuTide 121 Clinical Trial

NuCana will introduce the science behind NUC-1031, the medicine being compared in combination with cisplatin in the NuTide:121 study against the current standard of care in Biliary Tract Cancer, gemcitabine and cisplatin.

We will also provide an overview of previous study data, which has led to the initiation of the phase III study.

NCT Number:
ClinicalTrials.gov Identifier: NCT04163900